TTC39A antibody
Principal name
TTC39A antibody
Alternative names for TTC39A antibody
C1orf34, KIAA0452, DEME-6, Tetratricopeptide repeat protein 39A, TPR repeat protein 39A, Differentially expressed in MCF7 with estradiol protein 6
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Immunocytochemistry/Immunofluorescence (ICC/IF), Western blot / Immunoblot (WB)
Background of TTC39A antibody
- Kit Component:
- - KN318420G1, 4922503N01Rik gRNA vector 1 in pCas-Guide vector
- KN318420G2, 4922503N01Rik gRNA vector 2 in pCas-Guide vector
- KN318420D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Immunofluorescence of purified MaxPab antibody to C1orf34 on HeLa cell. [antibody concentration 10 ug/ml]
Western Blot analysis of TTC39A expression in transfected 293T cell line (H00022996-T01) by TTC39A MaxPab polyclonal antibody.Lane 1: C1orf34 transfected lysate(24.31 KDa).Lane 2: Non-transfected lysate.
CRISPR
| Catalog No. | Species | Donor Vector | |
|---|---|---|---|
| KN218567 | TTC39A - human gene knockout kit via CRISPR |
||
 |
Human | GFP-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN218567BN | TTC39A - human gene knockout kit via CRISPR |
||
|
Human | mBFP-Neo |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN218567LP | TTC39A - human gene knockout kit via CRISPR |
||
|
Human | Luciferase-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN218567RB | TTC39A - human gene knockout kit via CRISPR |
||
|
Human | RFP-BSD |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN318420 | Ttc39a - mouse gene knockout kit via CRISPR |
||
|
Mouse | GFP-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN318420BN | Ttc39a - mouse gene knockout kit via CRISPR |
||
|
Mouse | mBFP-Neo |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN318420LP | Ttc39a - mouse gene knockout kit via CRISPR |
||
|
Mouse | Luciferase-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN318420RB | Ttc39a - mouse gene knockout kit via CRISPR |
||
|
Mouse | RFP-BSD |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP327319 | TTC39A (transcript variant 1) |
||||
| Recombinant protein of human tetratricopeptide repeat domain 39A (TTC39A), transcript variant 1 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€680.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY421049 | TTC39A overexpression lysate |
|
|
0.1 mg /
€495.00
|
|
| OriGene Technologies, Inc. |
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC218567L2V | Lenti ORF particles, TTC39A (mGFP-tagged) - Human tetratricopeptide repeat domain 39A (TTC39A), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,267.00
|
|
| OriGene Technologies, Inc. | ||
| RC218567L1V | Lenti ORF particles, TTC39A (Myc-DDK tagged) - Human tetratricopeptide repeat domain 39A (TTC39A), transcript variant 2 , 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,133.00
|
|
| OriGene Technologies, Inc. | ||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR217401L2V | Lenti ORF particles, Ttc39a (GFP-tagged) - Mouse tetratricopeptide repeat domain 39A (Ttc39a), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,257.00
|
|
| OriGene Technologies, Inc. | ||
| MR217401L1V | Lenti ORF particles, Ttc39a (Myc-DDK-tagged) - Mouse tetratricopeptide repeat domain 39A (Ttc39a), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,123.00
|
|
| OriGene Technologies, Inc. | ||
| MR209041L1V | Lenti ORF particles, Ttc39a (Myc-DDK-tagged) - Mouse tetratricopeptide repeat domain 39A (Ttc39a), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,123.00
|
|
| OriGene Technologies, Inc. | ||
